NCT00522795 2020-02-17
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
Brown University
Phase 2 Completed
Clinical Trials
10 trialsNCT01402063 2020-02-17
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Brown University
Phase 2 Completed
NCT00045682 2017-07-13
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Completed
NCT01227408 2017-05-02
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
University of Southern California
Phase 2 Withdrawn
NCT00459810 2017-04-28
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT00352690 2016-12-12
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT00265733 2016-12-06
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00487669 2014-01-09
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
Dartmouth-Hitchcock Medical Center
Phase 2 Completed
NCT00069901 2008-09-22
Phase II CT-2103/Carboplatin in Ovarian Cancer
CTI BioPharma
Phase 2 Completed
NCT00148707 2007-12-21
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed